Advanced Search
LIU Weiling, DONG Bing, GUO Yongjun. Review of Targeted Therapy for Breast Cancer with BRCA Genes Mutation[J]. Cancer Research on Prevention and Treatment, 2017, 44(1): 75-78. DOI: 10.3971/j.issn.1000-8578.2017.01.016
Citation: LIU Weiling, DONG Bing, GUO Yongjun. Review of Targeted Therapy for Breast Cancer with BRCA Genes Mutation[J]. Cancer Research on Prevention and Treatment, 2017, 44(1): 75-78. DOI: 10.3971/j.issn.1000-8578.2017.01.016

Review of Targeted Therapy for Breast Cancer with BRCA Genes Mutation

  • Breast cancer is the most common cancer in female malignant tumors. BRCA1 and BRCA2 are the important susceptibility genes, and have a close relationship with the incidence of breast cancer. Currently, the targeted drugs of breast cancer with BRCA mutations become a research hotspot. This article is to sum up the connection between BRCA genes and breast cancer, and review on related targeted therapy methods.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return